GUAIFENESIN 400MG (GUAIFENESIN) TABLET [MARLEX PHARMACEUTICALS INC]

  • Home
  • GUAIFENESIN 400MG (GUAIFENESIN) TABLET [MARLEX PHARMACEUTICALS INC]

GUAIFENESIN 400MG (GUAIFENESIN) TABLET [MARLEX PHARMACEUTICALS INC]
PDF | XML
NDC 10135-682-30, 10135-682-60
Set ID 43ca292e-3128-47fc-9f20-b7e8c8677d4d
Category HUMAN OTC DRUG LABEL
Packager Marlex Pharmaceuticals Inc
Generic Name
Product Class
Product Number
Application Number PART341
View All Sections
  • SPL UNCLASSIFIED SECTION

    GUAIFENESIN 400MG TABLETS

    Marlex Pharmaceuticals, Inc.

    ----------

    Drug Fact

  • Active ingredient (in each tablet)

    Guaifenesin 400mg

  • Purpose

    Expectorant

    Guaifenesin 400 mg Tablets

  • Uses

    helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageway of bothersome mucus and make coughs more productive

  • Warnings

    Ask a doctor before use if you have

    • Persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • Cough accompanied by too much phlegm (mucus)

    Stop use and ask a doctor if

    cough last more than 7 days, come back or is accompanied by fever, rash, or persistent headache. There could be signs of a serious illness. 

    TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

     

    If pregnant or breast- feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions:

    • Do not take more than 6 doses in any 24-hour period.
    • This product is not intended for use in children under 12 years of age
    • Adults & children 12 years and over: 1 to 2 tablets every 4 hours
    • Children under 12 years: do not use
  • Other Information:

    • Store at 15°C-30°C (59°F-86°F)
  • Inactive Ingredients:

    Colloidal silicon dioxide, FD&C RED #40(AI-lake), magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, stearic acid

    Manufactured for & Distributed by:

    Marlex Pharmaceuticals, Inc.

    New Castle, DE 19720

    Rev: 02/19TCL

  • PRINCIPAL DISPLAY PANEL

    NDC 10135-0682-30
    Guaifenesin
    400 mg
    30 CAPLETS

    PRINCIPAL DISPLAY PANEL NDC 10135-0682-30 Guaifenesin 400 mg 30 CAPLETS

    PRINCIPAL DISPLAY PANEL NDC 10135-0682-30 Guaifenesin 400 mg 30 CAPLETS

  • PRINCIPAL DISPLAY PANEL

    NDC 10135-0682-60
    Guaifenesin
    400 mg
    60 CAPLETS

    PRINCIPAL DISPLAY PANEL NDC 10135-0682-60 Guaifenesin 400 mg 60 CAPLETS

    PRINCIPAL DISPLAY PANEL NDC 10135-0682-60 Guaifenesin 400 mg 60 CAPLETS

  • INGREDIENTS AND APPEARANCE
    GUAIFENESIN 400MG 
    guaifenesin tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10135-682
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POVIDONE (UNII: FZ989GH94E)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeCAPSULE (Caplet) Size10mm
    FlavorImprint Code G400
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:10135-682-3030 in 1 BOTTLE; Type 0: Not a Combination Product03/01/2019
    2NDC:10135-682-6060 in 1 BOTTLE; Type 0: Not a Combination Product03/01/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34103/01/2019
    Labeler - Marlex Pharmaceuticals Inc (782540215)
View All Sections

Related Drugs

Search DailyMed Drugs